The program provides pharmaceutical manufacturers with auditable, primary emissions data and verified proof of a 30% CO? reduction across DFE Pharma’s lactose portfolio
The company has commissioned a new plant at Khanna (Punjab), which has begun commercial production
Launched in August 2025, GSK India’s Oncology business is rapidly gaining momentum
The revenues this quarter are in line with the outlook we envisaged for the year
The therapy is currently completing Phase 1 clinical trials in renal cell carcinoma and non-small cell lung cancer
The company recorded consolidated revenue of Rs. 660 crore in Q3 FY26, up
Profitability metrics showed a sharper upward trend. Gross margin expanded 280 basis points to 61.2%
A nationwide network of over 1,000 accredited clinical trial sites will be created to accelerate drug development timelines and enhance research credibility
The Union Budget makes a clear and timely choice by placing biopharma at the centre of India’s next manufacturing wave
Subscribe To Our Newsletter & Stay Updated
